| Stage | SNX | % of rev | CLMB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $21.6B | 100.00% | $174M | 100.00% | SNX ×123.75 |
| Gross profit | $1.4B | 6.61% | $30M | 17.31% | CLMB +10.7pp |
| Operating income | $643M | 2.98% | $7M | 4.24% | CLMB +1.3pp |
| Pre-tax income | $555M | 2.58% | $8M | 4.33% | CLMB +1.8pp |
| Net income | $416M | 1.93% | $6M | 3.17% | CLMB +1.2pp |
| Stage | SNX | CLMB | Gap · A − B |
|---|---|---|---|
| Revenue | $21.6B100.00% | $174M100.00% | SNX ×123.75 |
| Gross profit | 6.61%$1.4B | 17.31%$30M | CLMB +10.7pp |
| Operating income | 2.98%$643M | 4.24%$7M | CLMB +1.3pp |
| Pre-tax income | 2.58%$555M | 4.33%$8M | CLMB +1.8pp |
| Net income |
| 1.93%$416M |
| 3.17%$6M |
| CLMB +1.2pp |
No shared counterparties.